6 ISSUES FOR JUST £6 Subscribe to Business & Professional Life today CLICK HERE

Oxfordshire-based Brainomix's stroke technology predicts patient recovery

PUBLISHED: 15:10 28 August 2018 | UPDATED: 15:10 28 August 2018

e-ASPECTS stroke technology

e-ASPECTS stroke technology

Archant

Brainomix is celebrating after a new study praised the usefulness of it’s e-ASPECTS stroke technology in hospitals

The technology allows clinicians - whatever their experience - to interpret CT brain scans on their mobile phones or tablets and quickly implement life-saving treatment for stroke victims.

The study, led by Prof Craig Anderson from The George Institute for Global Health, looked at 1,480 real-life CT scans from 111 hospitals in 13 countries.

e-ASPECTS scores were correlated with baseline neurological severity and independently predicted poor outcomes for stroke patients following thrombolysis - a procedure to dissolve blood clots.

It also showed it was a strong predictor of patient outcomes after thrombolysis, with a 1% decrease in the e-ASPECTS score associated with a 19% higher risk of a poor outcome for the patient.

Professor Simon Nagel, from Heidelberg University Hospital, first author of the study said: “In this large international clinical trial database (ENCHANTED), e-ASPECTS clearly predicted baseline neurological severity and prognosis in thrombolysed acute ischemic stroke patients.” Dr Michalis Papadakis, Brainomix CEO, added: “It’s encouraging to see the results from studies which are so positive.

“e-ASPECTS proved to be an excellent tool to predict the recovery and risk of haemorrhage of stroke patients following thrombolysis.”

For more information, visit the Brainomix website.

Most Read

Most Read

Latest from the Cotswold Life